The Prevalence of Hepatitis C Virus Among Blood Donors Attending Samarra's General Hospital

Abstract

Aim: To measure the prevalence of hepatitis C virus (HCV) among blood donors attending Samarra’a General Hospital. Patients and Methods: A questionnaire was developed in line with the study objectives. It was administered to blood donors visiting blood bank. After they were administered, informed consent and assurance with regards to confidentiality were provided. Results: A total of 50 blood donors were surveyed. The majority were males (66%) and most of them (40%) were between 21-35 years old. The majority were married (64%) and with intermediate education (46%). (44%) of the blood donors had transmitted their disease (hepatitis C) to their life partners and family members. (82%) of the blood donors whom we surveyed were having a positive history of receiving blood for certain conditions. Surgery was the common risk factor among the surveyed blood donors with (62%). Conclusions: Among blood donors, 66% of them were males and then the majority of blood donors 82% with the previous history of blood transfusion were infected with HCV. In addition, regarding risk factors for HCV; the common risk factor was the surgery which was 62%.

Transfusion transmitted infections among blood donors of Kamenge Teaching Hospital blood bank in Burundi

“…CNTS and KTH Blood Banks all together being located in Bujumbura city; this difference can make us think about the increasing of HCV prevalence in Bujumbura general population or Bujumbura blood donors. The prevalence found is relatively higher compared to that found by Abid and Athraa 35 at Samarra's General Hospital (2.40%), Ping et al 36 among blood donors in China (0.16%) and. Bhatti et al 27 in Pakistan (1.50%).…”

“…Even if blood donors do not constitute a sufficient representative population for estimation of the prevalence of HBV in general population, this study shows that there is good progress in fighting against HBV. Even though, this prevalence is high compared to the countries where hepatitis B vaccination rate is high 35,36 .…”

Anti-hepatitis C antibody carriage and risk of liver impairment in rural-Cameroon: adapting the control of hepatocellular carcinoma for resource-limited settings

“…While some studies reported high HCVAb carriage: in the southern 12% [ 34 ], in the western 6.3% [ 35 ], numerous studies on the contrary revealed a relative much lower prevalence: 2.2% anti-HCV in the Northern [ 27 ], 0.6% in the eastern [ 36 ], 0.4% in the western [ 37 ], 4.8% in the Littoral Region [ 38 ], 1.44% in the center region [ 39 ]. Equally, various burden of anti-HCV antibodies have also been reported in community settings worldwide: 0.77% in Romania [ 40 ], 1.02% in Sudan [ 41 ], 1.2% in Madagascar [ 42 ], 2.4%in Iraq [ 43 ], 3.6% in India [ 44 ], 19.80% in Cairo [ 45 ]. It is known that anti-HCV seropositivity from population-based studies is used to compare levels of HCV infection [ 9 ].…”

Anti-Hepatitis C Antibody Carriage and Risk of Liver Impairment in Rural-Cameroon: Adapting the Control of Hepatocellular Carcinoma for Resource-Limited Settings

“…While some studies reported high HCVAb carriage: in the southern 12% [35], in the western6.3% [36], numerous studies on the contrary revealed a relative much lower prevalence: 2.2% anti-HCV in the Northern [37], 0.6% in the eastern [38], 0.4% in the western [39], 4.8% in the Littoral Region [40], 1.44% in the center region [41]. Equally, various burden of anti-HCV antibodies have also been reported in community settings worldwide: 0.77% in Romania [42], 1.02% in Sudan [43], 1.2% in Madagascar [44], 2.4%in Iraq [45], 3.6% in India [46], 19.80% in Cairo [47]. It is known that anti-HCV seropositivity from population-based studies is used to compare levels of HCV infection [9].…”